CClinicalTrials.gg
TerminatedNCT03485404B12-POCDUpdated Aug 4, 2021

Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients

An interventional study of methylcobalamin and Folic Acid in Post Operative Cognitive Dysfunction, sponsored by Xijing Hospital. Terminated at 13 sites in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2021-08-04.

Sponsored by Xijing Hospital · Not applicable, Interventional, and Prevention

Why this study was terminated
Due to slow recruiment. Only 40 patients were recruited in four years.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

Read the detailed description

Vitamin B12 has long been suggested to have neural nutrient effect and widely used in clinical settings for patients with peripheral nerve injury as well as complementary medicine for patients with CNS disorders, including cognitive dysfunction. Evidences showed that, although no significant improvement in cognitive function was observed in healthy elderly after vitamin B12 supplementation, some studies suggested that patients with pre-existing CNS disorder may benefit from Vitamin B12. Post operational cognitive dysfunction (POCD) is severe, and long-lasting complication that affects as high as 53% of patients in high risk surgeries. Age is an independent risk factor for POCD. Researches have shown that serum vitamin B12 level decrease with age, and methylcobalamin (active form of Vitamin B12) content in the frontal cortex of aged patients are lower than that of younger patients. However, there are no report on effect of preemptive supplementation of vitamin B12 on POCD incidence. Therefore, the current research is aimed to explore the preoperative methylcobalamin supplementation (500 mg, 3/day for 7 days before surgery) on incidence of POCD. Folic acid supplementation is a common companion for vitamin B12 treatment in clinical settings because they are in the same methionine cycle, increase of one may result in deficiency of another. So we added 5 mg, 1/day of folic acid with methylcobalamin in the treatment group.

This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.

02

Conditions studied

  • Post Operative Cognitive Dysfunction

Keywords

  • POCD
  • vitamin B12
  • folic acid
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    1. Age equals or over 65
    1. Scheduled for spinal or joint replacement surgery under general anesthesia,estimated surgery time over 2h.
    1. Signed written informed consent obtained
    1. Non-surgical Controls are age and sex - matched community elderly residents.

Exclusion criteria

Exclusion Criteria:

    1. Disease of the central nervous system that impairs cognitive function, including all kinds of dementia, and depression
    1. MMSE score \< 24
    1. Received education for less than 5 years
    1. Currently taking sedative or antidepressant drugs
    1. Has taken vitamin B12, folic acid or their derivatives (methycobalamin, cobalamin, tetrahydrofolic acid, etc.) within 6 months.
    1. Has accepted cardiac or neurological surgery within one year.
    1. Was admitted for other clinical trials within 3 month
    1. Patients that regularly taking drugs that affect vitamin B absorption, including colchicine, neomycin, salicylate.
    1. Has severe visual or auditory problems
    1. Alcohol or drug dependent (alcohol dependent: drank more than 100 mL of Chinese liqueur with alcohol concentration over 40% everyday for the past 3 months).
    1. Patients that are already admitted for this study can not be admitted the second time, no matter the cause of surgery
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    VB12+FA

    Patients will receive oral supplementation of 0.5mg methylcobalamin, 3/day and 5 mg folic acid, 1/day for 7 days before non-cardiac surgery.

    Drug: methylcobalamin · Drug: Folic Acid · Procedure: non-cardiac surgery · Behavioral: NPB test

  • Placebo comparator
    Placebo

    Patients with receive oral tablets of placebo for folic acid 1/d and placebo for methylcobalamin 3/d, which look exactly like the interventional drugs as oral supplementation for 7 days before non-cardiac surgery.

    Other: Placebo for methylcobalamin · Other: Placebo for folic acid · Procedure: non-cardiac surgery · Behavioral: NPB test

  • Other
    Non-surgical controls

    Age and sex-matched community elderly people are included for two sessions of NPB test evaluation for calculation of POCD incidence as normal control to in Z value calculation of POCd incidence to rule out learning effect.

    Behavioral: NPB test

Interventions

  • Drugmethylcobalamin

    methylcobalamin tablets, 0.5mg/tablet, 3 tablets/day.

    Also known as: vitamin B12, VB12

  • DrugFolic Acid

    folic acid tablets, 5mg/tablet, 1 tablet/day

    Also known as: vitamin B9

  • OtherPlacebo for methylcobalamin

    orange tablets that looks exactly like methylcobalamin

  • OtherPlacebo for folic acid

    yellow tablets that looks exactly like folic acid

  • Procedurenon-cardiac surgery

    patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention

  • BehavioralNPB test

    participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.

    Also known as: neuropsychological battery tests, assessment of POCD

05

What researchers measure

Primary outcomes

  1. Incidence of POCD at discharge or 7 days after operation

    POCD incidence is defined as two or more test of the neuropsychological battery declined as compared to preoperative baseline.

    Time frame: at discharge or at 7 days after operation if the patient is not discharged by then

Secondary outcomes

  1. Activity daily living score

    Telephone interview of activity daily living score (14 items, 1-4 points per item, ranging 14-56 points with 56 being the worst-unable to complete any task of everyday living.)

    Time frame: 3 months after operation

  2. Serum level of vitamin B12, folic acid and homocysteine

    Ten ml of venous blood will be collected from patients to test the differences of serum levels of vitamin B12, folic acid and homocysteine to show the effect of preoperative supplementation and surgery stimulation on these parameters.

    Time frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1

  3. Serum level of cystatin C and myeloid differentiation protein 2

    Ten ml of venous blood will be collected from patients to test the differences of serum levels of cystatin C and myeloid differentiation protein 2.

    Time frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1

  4. Length of hospital stay

    to see if our intervention could reduce the total days of patient spent in hospital,

    Time frame: Date from hospital admission to hospital discharge. This length is usually around 7-14 days. It may be longer if the patient have one or more complications. The length will be documented at patient discharge, up to 100 weeks.

  5. Incidence of in hospital complications

    Overall rate of perioperative major complications including hemorrhage, deep vein thrombosis, cardiovascular complications, respiratory complications, acute kidney injury, infection or second operative needed, during patient's hospital stay.

    Time frame: From date of hospital admission to date of hospital discharge after surgery. Usually 7-14 days, assessed up to 100 weeks.

06

Study locations

13 sites
  • Anhui Provincial Hospital
    Hefei, Anhui 230001, China
  • Shenzhen University General Hospital
    Shenzhen, Guangdong, China
  • The Third Hospital of Hebei Medical University
    Shijiazhuang, Hebei, China
  • Henan Provincial People's Hospital
    Zhengzhou, Henan, China
  • Nanjing Drum Tower Hospital
    Nanjing, Jiangsu 210008, China
  • First Affiliated Hospital of Xi'an Jiaotong University
    Xi'an, Shaanxi 710032, China
  • Shaanxi Provincial People's Hospital
    Xi'an, Shaanxi 710032, China
  • Tangdu Hospital
    Xi'an, Shaanxi 710032, China
  • Xijing Hospital
    Xi'an, Shaanxi 710032, China
  • Shandong Provincial Qianfoshan Hospital
    Jinan, Shandong, China
  • Shanghai 10th People's Hospital
    Shanghai, 200072, China
  • Shanghai Changzheng Hospital
    Shanghai, China
  • Shanghai Forth People's Hospital
    Shanghai, China
07

Registry details

Key details

Study ID
NCT03485404
Lead sponsor
Xijing Hospital
Collaborators
First Affiliated Hospital Xi'an Jiaotong University, Tang-Du Hospital, Shaanxi Provincial People's Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Anhui Provincial Hospital, Shanghai 10th People's Hospital
Responsible party
Lize Xiong (Professor, Xijing Hospital) — Principal investigator
First posted
Apr 2, 2018
Start date
Jan 10, 2019
Primary completion
Jul 29, 2021
Completion
Jul 29, 2021
Last update
Aug 4, 2021

Study contacts

Lize Xiong, M.D., Ph.D.
study chair · Xijing Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion